Progress on Parkinson's Research and Treatment
Our Movement Disorder Center led by Irene Litvan, MD, is now designated as a Center of Excellence. Find out about our progress in diagnosing and treating Parkinson's disease.
News about Phase 3 trial
Researchers at the UC San Diego School of Medicine have launched a Phase III clinical trial to evaluate the drug isradipine, a calcium channel blocker often used to treat high blood pressure, as a potential new treatment for Parkinson disease (PD).
Upcoming Video Rounds Schedule
Please RSVP for the Movement Disorder Video Rounds here.
To develop a personalized translational program in movement disorders that will improve patients' and families' quality of life and will advance research.
New patients: 800-926-8273
Follow-up Patients: 858-822-MOVE (6683)